DAPHNE TODD: Open Payments
NPI 1750691465 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $224 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Lundbeck LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $19 |
Products named: REXULTI, AUSTEDO XR, CAPLYTA, Auvelity, Kerendia, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across MS — which companies pay providers there.
